PROTONNAYa MAGNITNO-REZONANSNAYa SPEKTROSKOPIYa U BOL'NOGO S POSTINTOKSIKATsIONNYM DELIRIEM PRI OTRAVLENII BUTIROLAKTONOM

I A Voznyuk , A G Sinenchenko , A N Lodyagin , V E Savelo , T A Shumakova

Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) : 33 -35.

PDF
Russian Military Medical Academy Reports ›› 2019, Vol. 38 ›› Issue (3 (Прил)) :33 -35. DOI: 10.17816/rmmar26127
Articles
research-article

PROTONNAYa MAGNITNO-REZONANSNAYa SPEKTROSKOPIYa U BOL'NOGO S POSTINTOKSIKATsIONNYM DELIRIEM PRI OTRAVLENII BUTIROLAKTONOM

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
I A Voznyuk, A G Sinenchenko, A N Lodyagin, V E Savelo, T A Shumakova. PROTONNAYa MAGNITNO-REZONANSNAYa SPEKTROSKOPIYa U BOL'NOGO S POSTINTOKSIKATsIONNYM DELIRIEM PRI OTRAVLENII BUTIROLAKTONOM. Russian Military Medical Academy Reports, 2019, 38(3 (Прил)): 33-35 DOI:10.17816/rmmar26127

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

D.L. Zvosec. Adverse events, including death, associated with the use of 1,4-butanediol / D.L. Zvosec, S.W. Smith, J.R. McCutcheon, J. Spillane, B.J. Hall, E.A.// The New England Journal of Medicine. - 2001. 344(2):87-94.

[2]

P. Neu. [Course and complications of GHB detoxification treatment: a 1-year case series] / P. Neu // Nervenarzt. 2019 May, 90(5):509-515.

[3]

Г.А. Ливанов. Клинический случай острого тяжелого отравления 1,4 - бутандиолом девочки-подростка/ Г.А. Ливанов, А.Н. Лодягин, В.А. Казиахмедов, Л.М. Починяева, С.И. Глушков, Б.В. Батоцыренов, А.Л. // Анестезиология и реаниматология. - 2017.- Т.62, №4. - С. 297-300.

[4]

T.M. Brunt. Sociodemographic and substance use characteristics of γ-hydroxybutyrate (GHB) dependent inpatients and associations with dependence severity / T.M. Brunt, M.W. Koeter, N. Hertoghs, M.S. Noorden, W. Brink // Drug Alcohol Depend. - 2013. 1.131(3):316-9.

[5]

А.В. Сабаев , Голева О.П. Смертность населения Омской области в результате острых отравлений химической этиологии за 2003-2012 гг./ А.В. Сабаев , Голева О.П.// Общественное здоровье и здравоохранение.- 2013.- №3. - С. 9-12.

[6]

I.B. Anderson. Trends in γ -Hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003 / I.B. Anderson, S.Y. Kim, J.E. Dyer, C.B. Burkhardt, J.C. Iknoian, M.J. Walsh, P.D. Blanc//Ann Emerg Med 2006. 47(2):177-183.

[7]

R.M. Kamal. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention / R.M. Kamal, M.S. van Noorden, W. Wannet, H. Beurmanjer, B.A. Dijkstra, A. Schellekens //CNS Drugs. 2017 Jan. 31(1):51-64.

RIGHTS & PERMISSIONS

Voznyuk I.A., Sinenchenko A.G., Lodyagin A.N., Savelo V.E., Shumakova T.A.

PDF

64

Accesses

0

Citation

Detail

Sections
Recommended

/